Emerging Technologies | Neuroscience
Optogenetics is a neuromodulation technique that uses light to control cells in living tissue, typically neurons, that have been genetically modified to express light-sensitive ion channels. This technique has revolutionized neuroscience by enabling researchers to precisely control and monitor the activity of specific neural circuits with millisecond precision.
Some of the emerging trends in optogenetics include the use of optogenetic tools to study neuronal circuits, the use of optogenetic tools to control cell fate, and the use of optogenetic tools to study disease models.
See live data on companies, R&D, markets, and news
In order to access the link, you need a Mergeflow account.
Frequently asked questions about the trial
How does the trial work?
After you sign up, you'll receive an email from us with an account activation link. Over the course of the trial, we'll send you emails with tips and tricks. The trial ends automatically after 14 days. No further obligations on your part.
Does the trial include all features?
The trial includes all Analyst Plan features.
Will I be charged when my trial is up?
No. We do not ask for your credit card up front, so you will only be charged when you decide to buy a subscription.
Do I have to install anything?
No. Mergeflow is a SaaS software that runs in any modern web browser. And because it's a subscription, you get constant product updates.
Which payment options does Mergeflow offer?
You can pay your Innovator or Analyst subscription via credit card (American Express, MasterCard, Visa) or SEPA Direct Debits. The larger team plans, API and enterprise solutions can be paid via invoicing and bank transfer.
Does Mergeflow keep my data private?
Yes. We don't serve ads, we never sell anything you give us, and we protect your privacy.